Compare Regeneron Pharmaceuticals Inc (REGN) vs Utilities Select Sector SPDR Fund (XLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Regeneron Pharmaceuticals Inc vs Utilities Select Sector SPDR Fund — how do they compare? Regeneron Pharmaceuticals Inc trades at $803.07 (market cap $83.43B), while Utilities Select Sector SPDR Fund trades at $42.84. The key difference: Regeneron Pharmaceuticals Inc pays a 0.46% dividend while Utilities Select Sector SPDR Fund pays none, and Regeneron Pharmaceuticals Inc is trading nearer its 52-week high, Utilities Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals.
| REGN | XLU | |
|---|---|---|
Market Cap | $83.43B | — |
Sector | Health | — |
52-Week High | $852.03 | $47.73 |
52-Week Low | $555.51 | $41.59 |
Enterprise Value | $78.14B | — |
Dividend Yield | 0.46% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Regeneron Pharmaceuticals (REGN) trades at $810.31, down 2.1% on the day, with a bullish technical signal from moving averages and strong fundamental profitability. The company reported robust earnings beats in recent quarters, with Q3 2026 results pending, and maintains high gross margins above 84%. Cash flow improved significantly in 2025, and analyst sentiment is overwhelmingly positive with no sell ratings.
Outlook remains favorable given consistent earnings outperformance and solid financial health, but risks include a pending securities class action lawsuit and potential volatility from clinical trial outcomes. The stock trades above the consensus price target, suggesting near-term caution despite long-term growth prospects in biopharmaceuticals.
XLU trades at $43.45, up 0.86% with bearish technical signals from moving averages. The utilities ETF faces mixed sentiment as AI power demand expectations clash with regulatory headwinds in Texas. Recent dividend declaration of $0.28 for June 2026 provides income appeal, while technical indicators show RSI neutral but ADX signaling strong bearish momentum.
The outlook remains cautious with regulatory pressures on data-center growth offsetting AI power demand potential. Key resistance at $44 and support at $42 define near-term trading range. Utilities' defensive characteristics may appeal during economic uncertainty, but sector concentration risks and interest rate sensitivity warrant careful monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →About Utilities Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →
